chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had only pain and swelling  at the injection site with my first injection in August. After my second injection in September about 24 hours later I had a low grade fever, was overtired, body aches, nausea, light sensitivity  and migraine that lasted 2 days. The migraine has come and gone ever since with right eye spasms lasting for 2-3 days at a time. I haven?t had headaches like this since puberty over 20 years ago.
Swollen and pain in left armpit area; Swollen and pain in left Armpit area; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 02Mar2021 at 11:45 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9265) via an unspecified route of administration in the left arm on 09Feb2021 at 12:45 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03Mar2021 at 08:00, the patient experienced swollen and pain in left armpit area. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events swollen and pain in left armpit area were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Two seizures the following day (more severe from her typical seizure disorder) that led to ankle fracture in both ankles.
exhausted all the time/Tired all the time; difficulty walking; This is a spontaneous report from a contactable consumer. A 66-years-old male patient of an un-specified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in left arm (anatomical Location of Administration of Pfizer vaccine considered as suspect) on 29Mar2021 at 13:30 (at the age of 66-years-old) as DOSE 2, SINGLE for COVID-19 immunization. Medical history included ongoing multiple sclerosis. Patient was going to schedule for rehab due to the reaction patient had. Patient did not put it together at first until the day be-fore yesterday that this could be due to the vaccine. Concomitant medications included carbamazepine (CARBAMAZEPINE) taken for pain medication and fampridine (AMPYRA) (Lot-05399A Expiry- 2023) taken for multiple sclerosis and ever since taking he was 100%, start and stop date were not reported. Historical vaccine included: first dose of BNT162B2 (COMIRANTY; Solution for injection) as dose 1, single on 08Mar2021 (at the age of 66-years-old) for COVID-19 immunization. Patient was on a diet. History of all previous immunization with the Pfizer vaccine considered as suspect or patient age at first and subsequent immunizations if dates of birth or immunizations were not available. Additional vaccines administered on same date of the Pfizer suspect reported as none. No prior vaccinations (within 4 weeks). Patient tried to get the Flu shot which gets every year and they would not give it to patient. No adverse events following prior vaccinations. Two weeks later clarified as two to three weeks after getting the second dose of the Pfizer vaccine clarified event that occurred as patient was tired all the time. It was to the point patient could not do anything. Patient could walk around, but not as far. Patient was limited to where he could go. It was never like this before with Multiple Sclerosis. Patient spoke with his MS doctor and the doctor said it could be the vaccine. Up until a month ago even with MS and wearing a leg brace everything was fine. Within a couple of weeks was using a leg brace. Patient was limited to do anything. Patient did not put it together until yesterday that it could be the vaccine. Patient had no problems for a long time. Patient felt normal, then all of a sudden, boom. Adverse event on the COVID-19 Vaccine. Patient had a history of multiple sclerosis and after getting the vaccine patient had been very very tired. Patient has been tired all the time. It was to the point patient could not do anything. patient could walk around, but not as far. Patient was limited to where patient could go. It was never like this before with Multiple Sclerosis. Adverse events did not require a visit Emergency Room/Physician Office. Patient has an appointment scheduled. The outcome of the events were unknown.   The lot number was not provided. Information on lot number has been requested during follow up.
tachycardia, high fever of 104, prolonged fatigue, chills, dizzy, lightheaded, hypertension
FEVER UP TO 103, REDNESS AND SWELLING IN DELTOID MUSCLE AT SIGHT INJECTION, LUMP/KNOT ON UNDERSIDE OF ARM (ARMPIT), BODY ACHES AND FATIGUE -ALL STARTED ON DAY 1 STARTING 2-3 HOURS AFTER SHOT AND ARE STILL BOTHERING HER
I had headaches, they started about two weeks from my vaccination. It was for a continuous 24 hours; I was taking Ibuprofen and Tylenol, but it wasn't helping much.  It was like tension headaches; they were like a migraine.
Pt received MMR vaccine on 01/02/2002 after being counseled about not becoming pregnant for 3 months after vaccine. Pt denied pregnancy at that time. In for pregnancy test on 01/08/2002 with positive results. The last menstrual period was at 12/04/2001.
Got numb on right side of body and A-fib flared up.  Went to hospital and was discharge with no issues.
rash, itch, and swelling at injection site, fever the following morning that continued for apx. 12 hours. still itchy.
Pt recvd vax 10NOV92 & immed exp burning & felt the vax going in; 17NOV92 pt exp pain in the arm which radiated into shoulder; No further details were provided;
pain at the injection site.; redness at the injection site.; swelling at the injection site.; fever; shivering; headaches; loss of appetite; tiredness; pain in the legs/required and ED visit; pain in the buttocks/required and ED visit; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain, injection site erythema, injection site swelling, fever, shivering, headache, appetite lost, tiredness, leg pain and buttock pain. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site swelling, fever, shivering, headache, appetite lost, tiredness, leg pain and buttock pain were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling, fever, shivering, headache, appetite lost, tiredness, leg pain and buttock pain to be related to Shingrix.     Additional Information: Additional Information: GSK Receipt Date: 14-OCT-2022. Reporter's Comments: The reporter stated that after the administration the patient experienced pain, redness, and swelling at the injection site.  The reporter stated a week later the patient experienced fever, shivering, headaches, loss of appetite, tiredness, and pain in the buttocks and legs, which required and ED visit. The reporter was unwilling to provide consumer demographics and unable to provide product information. The vaccine administration facility is the same as primary reporter. The reporter did not gave consent to follow-up.
Within 24 hrs after immunization, mother reported infant had high-pitched cry which lasted 48 hrs but was afebrile.  Tylenol was given at time of immunization, four days later, no local reaction present, chest clear and infant asymptomatic.
Patient was inadvertently given high dose flu vaccine. 11/24/21 @ 2:50pm, RPh called and explained to him, he stated that he was feeling fine and would let the pharmacy know if anything changes.
Bilateral tonsil pain, head and throat pressure 6 min after vaccination. No problem drinking water. Given Benadryl 25 mg IM x1. Stable, released from vaccination site.
C/o pain in RUQ of abdomen. Dull, burning and constant x 4 days. On exam, in RUQ abdomen a group of about 25 small vesicles and smaller group of vesicles around side and back. Rx for VALTREX 1 gm TID x 7 days, Prednisone 40 mg x 7 days.
not sure if pt had Pfizer or mederna vaccination.  pt had myalgias, arthralgias, and intense fatigue
C/O DIZZINESS  WITH A FEELING SHE WILL FAINT. PT STATES THIS OCCURRS EVERYTIME SHE RECEIVES  A  SHOT.
A few minutes after receiving the vaccine I felt like I was fainting. My hearth was speeded up and I got pale.  Five hours after I still feel dizzy and have fever. Really tired. And have a really strong metal taste in my mouth from the moment I took the vaccine. Food doesnt have any taste.
Severe headache. chills, fever >101 F, nausea, exhaustion, general body aches, very  sore arm at injection site for 3 days.  OTC tx included Tylenol & bed rest w/lot of fluids
pt recv vax 23JAN96 & 5AUG96 pt exp a rash & severe itch w/10 pox on body including some on hands, abd & face;f/u indicated eczema and nonspecific rash not like varicella or zoster;
He was feeling lightheaded and dropped and twitched, partially seized and wetted himself. He then got up and felt nauseated.
pain at injection site - severe-starting 10 hours after lasting 5 days swelling at injection site - starting 10 hours after - lasted 2 days chills- severe- starting 11 hours after lasting 4 hours rigors - severe- starting 11 hours after lasting 4 hours sweats - mild  starting 11 hours after lasting 4 hours abdominal cramping - moderate -  starting 11 hours after lasting 11 hours Nausea - starting 28 hours after injection - lasting 4 hours
Directly after the immunization, patient experienced dizziness. Then the patient experienced dizziness, only at night, when turning over in bed for the proceeding 4-5 days.
Patient ran a fever of 100.2, had redness, swelling, and hardness at the injection site
Very dry cough before the vaccine with shortness of breath. After the vaccine just had pain in the arm, no other symptoms. I am a smoker. I went to a physical in August 2021 for my shortness of breath and after the 1st dose I felt like I had COVID-19 but it was negative but I felt that I did have COVID-19 because I had loss of taste.
After a week (7 days) I noticed I was short of breath and my heart was racing most of the day.  I had my blood pressure checked for several days by the school nurse.  The readings were very high 158 over 102 at the start of school and 168 over 104 at the end of the day.  This was constant for a week before I went to the cardiologist for a check up.   The doctor prescribed Amlodipine Besylate 5mg on March 26, 2021 to lower my blood pressure.  It took roughly 10 days to get my blood pressure down to 140 over 85.
From information received via fax at manufacturer on 1/20/03, it was reported that a 52 year old male received FLUZONE UNSP on an unspecified date. Reportedly, the patient developed transverse myelitis (unknown date of onset) and was hospitalized. An MRI and lumbar puncture were performed, but no results were available at the time of this report. The patient's recovery status was reported as not recovered. Additional information was received at manufacturer on 1/23/03 from the reporting physician. He reported that the patient received Fluzone, but he did not administer the product and does not know when the patient was vaccinated. The physician saw when he was admitted to the hospital on 1/17/03. At that time the patient had been having symptoms for approximately 2.5 months. The reporter does not have access to the patient's medical records at this time. No further information was provided.  Follow up on 07/07/2003: "From additional information received on 06/25/2003 and 06/30/2003, it was reported that the patient was treated by the reporting physician in the emergency room.  The physician does not have access to the patient's medical records.  The patient experienced transverse myelitis following the administration of Fluzone on an unspecified date.  It was previously reported that the patient also had transverse myelitis at the time of vaccination, however this was reported as being incorrect by the physician's office nurse.  No further information is anticipated, this case is considered closed."
Initial report was received on 16 December 2011 from an electronic lay press article. It represents a cluster of two patients reported by the same reporter who each experienced pertussis following vaccination with a pertussis vaccine (manufacturer not reported). The second patient is captured in case number 2011-12374. A 7-year-old patient (gender not reported) had received an injection of pertussis vaccine (manufacturer, lot number, route, site and date of administration not reported) and an unspecified amount of time later, developed pertussis. The patient was reported as up-to-date with immunizations. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives). At the time of the report, URTICARIA (hives) outcome was unknown. Not Provided    The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Pt recv vax on 1/8/99; on 1/9/99 pt exp sore throat x 2wk, chills, aches, pain, fever, raw/scratchy feeling in chest, difficulty swallowing
COVID-19; COVID-19; Flu like symptoms; This is a solicited report from a Non-Interventional Study based on information received by Pfizer from pharmaceutical company, manufacturer control number: 21K-163-4062611-00. A non- contactable patient reported that a 14-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 vaccine, formulation: solution for injection; Batch no/Lot Number: not reported) via intramuscularly on 13Aug2021 (at the age of 14-year-old) as dose 1, single for COVID-19 immunization; adalimumab (HUMIRA) via subcutaneously on an unknow date for an unknown indication. Medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced Covid-19 and flu like symptoms. It was unknown if the patient was enrolled in a COVID-19 vaccine trial. On an unknown date in 2021, the patient underwent lab tests which included covid-19 test: positive. PFIZER BIONTECH COVID-19 VACCINE (TOZINAMERAN) was also considered suspect. Causality for adalimumab (HUMIRA) the reporter's causality for the events of covid/flue like symptoms onset in 2021 was no reasonable possibility. The reporter's causality for the events of covid/flue like symptoms onset in 2021 was not provided. Outcome of the event Covid-19 was recovering, and other events was unknown.The reporter's assessment of the causal relationship of the event with the suspect products was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Based on the information, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events of  LOE. The case will be reassessed once new information is available.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 71 year old male patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On or about 06-OCT-2009, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced herpes zoster.   On an unspecified date, the patient was treated by a healthcare provider for herpes zoster. The outcome of the event herpes zoster was not reported. The reporter considered the event herpes zoster to be related to zoster vaccine live (ZOSTAVAX).  Additional information has been requested.
I received the second covid vaccine dose Sat afternoon. On Sunday I woke up with flu like symptoms, body-aches, temperature, headaches. I did not call my Dr. Drank fluids and slept. Monday morning started feeling better.
the second time was after I had the vaccine/suspected vaccination failure; I have had it twice; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (experienced shingles before vaccination).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 2-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had shingles twice, the second time was after the shingles vaccine. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles was not provided.
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 20-OCT-2015, the patient was vaccinated with the third dose of improperly stored ROTATEQ oral liquid (lot # L000571, expiration date 26-JUL-2016) (dose unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
PATIENT WAS TO HAVE RECEIVED BOOSTER DOSE OF MODERNA COVID-19 VACCINE (0.25ML) BUT PATIENT WAS ADMINISTERED A FULL DOSE (0.5ML).  PATIENT STATES SHE HAD NO ADVERSE EVENT AFTER RECEIVING IMMUNIZATION.
Tiredness; Headache; Muscle and joint aches; Muscle and joint aches; Feeling unwell; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 19Feb2021 13:00 (Batch/Lot Number: EL3247) as dose 2, single at 59 years old for COVID-19 immunization at a workplace clinic.  Medical history included hypertension and hyperlipidaemia from an unknown date. Concomitant medications included hydrochlorothiazide, triamterene (DYAZIDE) and atorvastatin both taken for an unspecified indication, start and stop date were not reported. The patient previously took Zoloft and experienced drug allergy. The patient previously received the first dose of bnt162b2 (lot number: EL3247) on 29Jan2021 at 01:30 PM on the left arm at 59 years old for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 20Feb2021, the patient experienced tiredness, headache, muscle and joint aches, and was feeling unwell. The reporter assessed the events as non-serious. The events did not result in death or life threatening condition, hospitalization, disability, or congenital anomaly. No treatment was received. The outcome of the events was recovering.   Follow-up attempts completed. No further information expected.
At 4am I woke up sweating/sweating profusely; nausea/extremely nauseous; dizziness/dizzy/extremely dizzy; vomit; lost bladder control; I was very weak,  I couldn't wipe. I couldn't hold a cloth/had no hand strength; terrified, I thought I was dying never experienced anything like this in my life/ she did not know if she was dying, she thought she it was possible, she never felt that way in her life; a little arm pain; This is a spontaneous report from a contactable consumer (patient) received via Medical Information Team.  A 73-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at deltoid left on 26Jan2021 at 13:20 (at the age of 73 years) at single dose for COVID-19 immunization. The patient medical history was none.  There were no concomitant medications.  The patient reported a little arm pain on 26Jan2021, I woke up sweating/sweating profusely, nausea/extremely nauseous, dizziness/dizzy/extremely dizzy and vomit , all on 27Jan2021 at 4:00; lost bladder control, terrified, I thought I was dying never experienced anything like this in my life/ she did not know if she was dying, she thought she it was possible, she never felt that way in her life, and those are classic heart attack symptoms, she had no cardio and respiratory symptoms; I was very weak, I couldn't wipe. I couldn't hold a cloth/had no hand strength, all on 27Jan2021. Therapeutic measures were taken as result of little arm pain an included treatment with aspirin. The patient outcome of the events was recovered.   The information on the batch number has been requested.
A female nurse of unknown age while handling OncoTICE accidentally squirted it into her eye. She subsequently experienced a little irritation to the eye.
Starting 24 hours after injection, employee started to develop a red, hot, tender patch of induration around the injection site.  This steadily increased in size and severity over days 2 and 3 post injection.  The reaction finally resolved 14 days after injection.
8 days after my 1st COVID19 vaccine (Moderna 03/18/2021), I had swollen lymph nodes under my right arm and a rash around the injection site.   1 day after my 2nd COVID19 vaccine, I had fever, chills,  headaches, swollen lymph nodes in my right neck and under my left arm, 8 days after my 2nd COVID19 vaccine I couldn't walk I was in so much pain and was taken to the Hospital and seen my the emergency room.  They advised gave me an injection of a steriod and a pain medicine and was released.  Two days later on May 2nd, I was admitted to the Hospital with an acute Left Herniation at L5S1 causing an impingement of the left L5 nerve root contacting the Left S1. I know the herniation was caused by the COVID 19 vaccine; however, I believe the extra inflammation caused my body to react negatively to the vaccine.  I am very apprehensive about  taking a booster.